Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Abigaelle Gros"'
Autor:
Rita El Helou, Guillaume Pinna, Olivier Cabaud, Julien Wicinski, Ricky Bhajun, Laurent Guyon, Claire Rioualen, Pascal Finetti, Abigaelle Gros, Bernard Mari, Pascal Barbry, Francois Bertucci, Ghislain Bidaut, Annick Harel-Bellan, Daniel Birnbaum, Emmanuelle Charafe-Jauffret, Christophe Ginestier
Publikováno v:
Cell Reports, Vol 18, Iss 9, Pp 2256-2268 (2017)
Summary: Breast cancer stem cells (bCSCs) have been implicated in tumor progression and therapeutic resistance; however, the molecular mechanisms that define this state are unclear. We have performed two microRNA (miRNA) gain- and loss-of-function sc
Externí odkaz:
https://doaj.org/article/46925da2e0104ddc8a207b5df794202d
Autor:
Abir Arfaoui, Claire Rioualen, Violette Azzoni, Guillaume Pinna, Pascal Finetti, Julien Wicinski, Emmanuelle Josselin, Manon Macario, Rémy Castellano, Candi Léonard‐Stumpf, Anthony Bal, Abigaelle Gros, Sylvain Lossy, Maher Kharrat, Yves Collette, Francois Bertucci, Daniel Birnbaum, Hayet Douik, Ghislain Bidaut, Emmanuelle Charafe‐Jauffret, Christophe Ginestier
Publikováno v:
EMBO Molecular Medicine, Vol 11, Iss 10, Pp n/a-n/a (2019)
Abstract Therapeutic resistance is a major clinical challenge in oncology. Evidence identifies cancer stem cells (CSCs) as a driver of tumor evolution. Accordingly, the key stemness property unique to CSCs may represent a reservoir of therapeutic tar
Externí odkaz:
https://doaj.org/article/c9002abaa4bb472dafea9936d6b75e8c
Autor:
Pascal Finetti, Claire Rioualen, François Bertucci, Bernard Mari, Julien Wicinski, Abigaelle Gros, Ricky Bhajun, Christophe Ginestier, Pascal Barbry, Olivier Cabaud, Guillaume Pinna, Daniel Birnbaum, Laurent Guyon, Ghislain Bidaut, Annick Harel-Bellan, Rita El Helou, Emmanuelle Charafe-Jauffret
Publikováno v:
Cell Reports
Cell Reports, Elsevier Inc, 2017, 18 (9), pp.2256-2268. 〈10.1016/j.celrep.2017.02.016〉
Cell Reports, Elsevier Inc, 2017, 18 (9), pp.2256-2268. ⟨10.1016/j.celrep.2017.02.016⟩
Cell Reports, Vol 18, Iss 9, Pp 2256-2268 (2017)
Cell Reports, 2017, 18 (9), pp.2256-2268. ⟨10.1016/j.celrep.2017.02.016⟩
Cell Reports, Elsevier Inc, 2017, 18 (9), pp.2256-2268. 〈10.1016/j.celrep.2017.02.016〉
Cell Reports, Elsevier Inc, 2017, 18 (9), pp.2256-2268. ⟨10.1016/j.celrep.2017.02.016⟩
Cell Reports, Vol 18, Iss 9, Pp 2256-2268 (2017)
Cell Reports, 2017, 18 (9), pp.2256-2268. ⟨10.1016/j.celrep.2017.02.016⟩
Summary: Breast cancer stem cells (bCSCs) have been implicated in tumor progression and therapeutic resistance; however, the molecular mechanisms that define this state are unclear. We have performed two microRNA (miRNA) gain- and loss-of-function sc
Autor:
Nathalie Baeza-Kallee, Raphaël Bergès, Victoria Hein, Stéphanie Cabaret, Jeremy Garcia, Abigaëlle Gros, Emeline Tabouret, Aurélie Tchoghandjian, Carole Colin, Dominique Figarella-Branger
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 14, p 11645 (2023)
Glioblastoma (GBM) contains cancer stem cells (CSC) that are resistant to treatment. GBM CSC expresses glycolipids recognized by the A2B5 antibody. A2B5, induced by the enzyme ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyl transferase 3 (ST8Sia3), p
Externí odkaz:
https://doaj.org/article/1ee6d20a7d0c46c6b671819ac8964613